BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 21205897)

  • 1. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.
    Ren D; Villeneuve NF; Jiang T; Wu T; Lau A; Toppin HA; Zhang DD
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1433-8. PubMed ID: 21205897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway.
    Xiang Y; Ye W; Huang C; Yu D; Chen H; Deng T; Zhang F; Lou B; Zhang J; Shi K; Chen B; Zhou M
    Oxid Med Cell Longev; 2018; 2018():2360427. PubMed ID: 29849873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C.
    Cheng C; Yuan F; Chen XP; Zhang W; Zhao XL; Jiang ZP; Zhou HH; Zhou G; Cao S
    Biomed Pharmacother; 2021 Oct; 142():111652. PubMed ID: 34112534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2.
    Olayanju A; Copple IM; Bryan HK; Edge GT; Sison RL; Wong MW; Lai ZQ; Lin ZX; Dunn K; Sanderson CM; Alghanem AF; Cross MJ; Ellis EC; Ingelman-Sundberg M; Malik HZ; Kitteringham NR; Goldring CE; Park BK
    Free Radic Biol Med; 2015 Jan; 78():202-12. PubMed ID: 25445704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic activities of brusatol in human non-small cell lung cancer cells: Involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response.
    Xie J; Lai Z; Zheng X; Liao H; Xian Y; Li Q; Wu J; Ip S; Xie Y; Chen J; Su Z; Lin Z; Yang X
    Toxicology; 2021 Mar; 451():152680. PubMed ID: 33465425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis.
    Vartanian S; Ma TP; Lee J; Haverty PM; Kirkpatrick DS; Yu K; Stokoe D
    Mol Cell Proteomics; 2016 Apr; 15(4):1220-31. PubMed ID: 26711467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
    Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
    Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flumethasone enhances the efficacy of chemotherapeutic drugs in lung cancer by inhibiting Nrf2 signaling pathway.
    Zhou Y; Zhou Y; Wang K; Li T; Yang M; Wang R; Chen Y; Cao M; Hu R
    Cancer Lett; 2020 Apr; 474():94-105. PubMed ID: 31954771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3',4',5',5,7-pentamethoxyflavone sensitizes Cisplatin-resistant A549 cells to Cisplatin by inhibition of Nrf2 pathway.
    Hou X; Bai X; Gou X; Zeng H; Xia C; Zhuang W; Chen X; Zhao Z; Huang M; Jin J
    Mol Cells; 2015 May; 38(5):396-401. PubMed ID: 25843086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
    Yu X; He Z; Wang Z; Ke S; Wang H; Wang Q; Li S
    Exp Cell Res; 2024 May; 438(2):114053. PubMed ID: 38663476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage.
    Sun X; Wang Q; Wang Y; Du L; Xu C; Liu Q
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
    Chian S; Thapa R; Chi Z; Wang XJ; Tang X
    Biochem Biophys Res Commun; 2014 May; 447(4):602-8. PubMed ID: 24747074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
    Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
    Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydrobruceine B enhances the cisplatin-induced cytotoxicity through regulation of the mitochondrial apoptotic pathway in lung cancer A549 cells.
    Huang Z; Yang G; Shen T; Wang X; Li H; Ren D
    Biomed Pharmacother; 2017 May; 89():623-631. PubMed ID: 28262615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.
    Wang XJ; Sun Z; Villeneuve NF; Zhang S; Zhao F; Li Y; Chen W; Yi X; Zheng W; Wondrak GT; Wong PK; Zhang DD
    Carcinogenesis; 2008 Jun; 29(6):1235-43. PubMed ID: 18413364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UVA Irradiation Enhances Brusatol-Mediated Inhibition of Melanoma Growth by Downregulation of the Nrf2-Mediated Antioxidant Response.
    Wang M; Shi G; Bian C; Nisar MF; Guo Y; Wu Y; Li W; Huang X; Jiang X; Bartsch JW; Ji P; Zhong JL
    Oxid Med Cell Longev; 2018; 2018():9742154. PubMed ID: 29670684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-methoxychalcone enhances cisplatin-induced oxidative stress and cytotoxicity by inhibiting the Nrf2/ARE-mediated defense mechanism in A549 lung cancer cells.
    Lim J; Lee SH; Cho S; Lee IS; Kang BY; Choi HJ
    Mol Cells; 2013 Oct; 36(4):340-6. PubMed ID: 24046186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy.
    Zhang D; Hou Z; Aldrich KE; Lockwood L; Odom AL; Liby KT
    Mol Cancer Ther; 2021 Sep; 20(9):1692-1701. PubMed ID: 34158350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.